The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man.

1 The pharmacokinetics of diethylcarbamazine (DEC) were studied in twelve patients with chronic renal function impairment. 2 Selected pharmacokinetic parameters, plasma half-life (T1/2), area under the plasma concentration-time curve (AUC), elimination rate constant (Kel) and 24 h urinary excretion...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Adjepon-Yamoah, K K, Edwards, G, Breckenridge, A M, Orme, M L, Ward, S A
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1982
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1402015/
https://ncbi.nlm.nih.gov/pubmed/7093114
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi